TY - JOUR
T1 - How to define a quadruple aim framework to assess value in critical pathway of the patients with Clostridioides difficile infection
AU - De Belvis, Antonio
AU - Fratini, Antonio
AU - Angioletti, C.
AU - Morsella, Alisha
AU - Ruggeri, Maria Rita Giuseppina
AU - Pepe, Gilda
AU - Ianiro, Gianluca
AU - Settanni, Carlo Romano
AU - Gasbarrini, Antonio
AU - Cammarota, Giovanni
PY - 2021
Y1 - 2021
N2 - OBJECTIVE: The study aims to define the set of Key Performance Indicators (KPIs) required to assess the Value delivered by managing patients with Clostridioides difficile infection through a Critical Pathway. We used the quadruple aim Value-Based approach, and we validated the set of KPIs with the Delphi method. MATERIALS AND METHODS: The study focuses on patients on board a Critical Pathway on Clostridioides difficile Infection and targeted towards a Fecal Microbiota Transplantation (FMT). FMT has been used to successfully treat recurrent Clostridium difficile infection. A two-round e-Delphi survey collecting data was conducted in 2019-2020 to validate the Value-Based evaluation tool. The Value-Based criteria taken into account are Clinical Outcomes, Experience of Care, Per-capita cost, Physician's burnout. RESULTS: The two rounds led to the validation of 50 items, and four primary clinical outcomes (Mortality rate, length of stay, readmission and complications related to the illness). CONCLUSIONS: The evaluation tool included is validated in its totality and can provide a comprehensive overview of the Value created by the Critical pathway for patients with Clostridioides difficile. We can extend the approach illustrated in this study can also to evaluate other Critical pathways.
AB - OBJECTIVE: The study aims to define the set of Key Performance Indicators (KPIs) required to assess the Value delivered by managing patients with Clostridioides difficile infection through a Critical Pathway. We used the quadruple aim Value-Based approach, and we validated the set of KPIs with the Delphi method. MATERIALS AND METHODS: The study focuses on patients on board a Critical Pathway on Clostridioides difficile Infection and targeted towards a Fecal Microbiota Transplantation (FMT). FMT has been used to successfully treat recurrent Clostridium difficile infection. A two-round e-Delphi survey collecting data was conducted in 2019-2020 to validate the Value-Based evaluation tool. The Value-Based criteria taken into account are Clinical Outcomes, Experience of Care, Per-capita cost, Physician's burnout. RESULTS: The two rounds led to the validation of 50 items, and four primary clinical outcomes (Mortality rate, length of stay, readmission and complications related to the illness). CONCLUSIONS: The evaluation tool included is validated in its totality and can provide a comprehensive overview of the Value created by the Critical pathway for patients with Clostridioides difficile. We can extend the approach illustrated in this study can also to evaluate other Critical pathways.
KW - Clostridioides difficile
KW - Delphi
KW - Fecal microbiota transplantation
KW - Key performance indicator
KW - PCA/PDTA implementation
KW - Value-based
KW - Clostridioides difficile
KW - Delphi
KW - Fecal microbiota transplantation
KW - Key performance indicator
KW - PCA/PDTA implementation
KW - Value-based
UR - http://hdl.handle.net/10807/192806
U2 - 10.26355/eurrev_202107_26252
DO - 10.26355/eurrev_202107_26252
M3 - Article
SN - 1128-3602
VL - 25
SP - 4597
EP - 4610
JO - European Review for Medical and Pharmacological Sciences
JF - European Review for Medical and Pharmacological Sciences
ER -